SUREFIRE RESOURCES NL — Board/Management Information 2009

Jan 29, 2009

ABN 48 083 274 024 Level 1, 248 Hay Street, SUBIACO WA 6008 Telephone 61 8 9381 6922 Facsimile 61 8 9381 6060

30 January 2009

Manager Announcements Company Announcements Office Australian Securities Exchange Limited 20 Bridge St SYDNEY NSW 2000.

Dear Sir/Madam,

APPOINTMENT OF MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER

Genesis Biomedical Limited wishes to announce the appointment of Mr Gordon Hatch as Managing Director and Chief Executive Officer of the Company effective from 31st January, 2009. Mr Hatch was appointed as a Non-Executive Director of the Company on 18[th] September 2008.

Mr Hatch has in excess of 25 years of practical experience in management, commerce and mining associated with both local and overseas directorships of his own companies. In particular, he has been responsible for negotiating and introducing new systems to various industries with a broad range of clientele including publicly listed national companies and government.

He has represented Western Australia in trade missions to Indonesia and has had a strong link in Asia for the past 18 years through his business interests in both Singapore and the Philippines.

Mr Hatch will receive remuneration of $120,000 to be reviewed in six months by the Board, four weeks annual leave, a motor vehicle allowance and, subject to shareholder approval at the next General Meeting of the Company, Incentive Options (number yet to be approved by the Board) under a Share Price Appreciation Incentives arrangement once pre-determined share price performance criteria are met.

As announced to the ASX on 31[st] December 2008, Mr Don Valentino was to resign as Managing Director and CEO of the Company effective from 31[st] March 2009. This resignation will now be effective from 31st January 2009.

Yours faithfully,

GENESIS BIOMEDICAL LIMITED

==> picture [215 x 32] intentionally omitted <==

David Semmens

Company Secretary